Oncology

Latest News

FDA approved. | Image Credit: Pawel - stock.adobe.com .jpeg

FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors

By Pearl Steinzor

January 2nd 2025

FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.

gastric cancer | Image credit: Crystal light - stock.adobe.com

FDA Approves Tislelizumab-jsgr as First-Line Therapy for HER2– Gastric Cancers

By Skylar Jeremias

January 2nd 2025

ICYMI: Highlights From ACCC Fall 2024

By Pearl Steinzor

January 1st 2025

Top 5 Most-Read Oncology Articles of 2024

Top 5 Most-Read Oncology Content of 2024

By Pearl Steinzor

December 25th 2024

Most Popular Articles of 2024 in Evidence-Based Oncology

By Mary Caffrey

December 23rd 2024

Join this panel as they discuss treatment for metastatic NSCLC patients without driver mutations.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

August 22nd 2016

Researchers Propose a Bundled Payment Model for Breast Screening

Surabhi Dangi-Garimella, PhD

A new report by the Harvey L. Neiman Health Policy Institute recommends a bundled payment model for breast cancer screening, with the objective of improved patient care and a more efficient use of healthcare resources.

August 22nd 2016

Adverse Sociodemographic Conditions Reduce Survival in Younger Patients With Multiple Myeloma

Surabhi Dangi-Garimella, PhD

Factors such as insurance status and being married are significant determinants of survival compared with race/ethnicity, in patients with multiple myeloma who are less than 65 years of age.

August 20th 2016

This Week in Managed Care: August 20, 2016

This week, the top stories in managed care included Aetna's announcement that it was pulling back its participation on the Affordable Care Act exchanges, the annual meeting of the American Association of Diabetes Educators outlined how existing sites can help roll out the Diabetes Prevention Program nationwide, and hospital leaders gave their opinions on CMS' hospital readmission program.

August 19th 2016

The Toll of Cancer Care - Clinical and Financial Toxicity

Joseph Alvarnas, MD

This issue of Evidence-Based Oncology is dedicated to understanding the implications, scope, and opportunities within the realm of cost sharing in oncology.

August 19th 2016

Does the Cost-Sharing Burden Influence Cancer Outcomes?

Surabhi Dangi-Garimella, PhD

Financial burden is a potential nonclinical adverse event in cancer patients. As patients, especially those in the lower income ranges and the middle class, struggle to meet their medical bills, the likelihood of them skipping doses or doctor’s visits is quite high.

August 19th 2016

Young Adult Cancer Survivors Disproportionately Affected by Treatment Costs

Samantha Watson, MBA Michelle Landwehr, MPH

Young adult (YA) cancer survivors are hit the hardest in the wallet by their treatment. The average net worth of YAs who have received grants from The Samfund is a staggering —$35,000, while their counterparts in the general population is $68,000

August 19th 2016

Precision Oncology: Why Payers Should Initiate CGP Coverage Now!

Jerry Conway Ingrid Marino, MS, CGC

Precision oncology, or the clinically and financially efficient use of genomically matched treatments and clinical trials, is evolving as a potentially important starting point for cancer care within successful alternative payment models.

August 19th 2016

Proton Therapy Eliminates Unnecessary Radiation Exposure and Is Medically Necessary

Steven J. Frank, MD

When it comes to health coverage, most Americans face an unnerving reality-they have no idea what is covered under their health insurance policy until after they are affected by illness or disease.

August 19th 2016

Patient Access to Reference Pricing Prompts Choice of Lower-Cost Testing Laboratories, Cost Savings

Surabhi Dangi-Garimella, PhD

A study by researchers at the University of California, Berkeley, found that patients who have access to the prices charged by a testing laboratory, as well as reference pricing, choose lower-cost laboratories, a move that results in overall cost savings.

August 19th 2016

California Experiment Will Let Pathologists Report Cancer Diagnoses in Real Time

Surabhi Dangi-Garimella, PhD

A collaborative pilot that involves the California Department of Public Health, St. Joseph Health in Orange County, and UCSF Benioff Children’s Hospital in Oakland is studying whether near—real-time reporting of cancer diagnoses by pathologists, using standardized electronic forms, will permit providers to make more informed and timely treatment decisions.

August 19th 2016

Breakthrough for Daratumumab for Use as Second-Line Treatment With Standard of Care in Multiple Myeloma

Surabhi Dangi-Garimella, PhD

The monoclonal antibody daratumumab (Darzalex) has been granted Breakthrough designation, the second for this drug, for use in combination with either lenalidomide (Revlimid) and dexamethasone or bortezomib (Velcade) and dexamethasone for patients with multiple myeloma who have received at least 1 prior therapy.

August 19th 2016

The Risk of T2D in Individuals With Benign Adrenal Tumors

Surabhi Dangi-Garimella, PhD

Adrenal gland tumors that are defined as being nonfunctional may not really be so, and the hormones that these tumors secrete could increase an individual’s risk of cardiometabolic irregularities, according to a new study.

August 19th 2016

Nivolumab Passes QOL Test in Melanoma

Surabhi Dangi-Garimella, PhD

Results from the CheckMate 066 study found that the checkpoint inhibitor nivolumab, which has proven highly efficient in the treatment of melanoma, also performs well in improving the patient’s long-term quality of survival benefit in patients with advanced melanoma.

August 19th 2016

NEJM Study First to Identify Mutations Responsible for Relapse in PD-1 Inhibitor—Treated Melanoma

Surabhi Dangi-Garimella, PhD

Loss-of-function mutations in Janus kinase 1 (JAK1) or Janus kinase 2 (JAK2), deletion of the wild-type allele of JAK1 or JAK2, and truncation in the antigen-presenting protein beta-2-microglobulin (B2M) gene have been found responsible for lack of response to interferon gamma in patients with melanoma.

August 19th 2016

Paying to Make Health IT Meaningful: A Discussion at the NCCN Policy Summit

Surabhi Dangi-Garimella, PhD

Maximizing the utility of technology platforms and making them meaningful to ensure quality cancer care was the underlying theme of Emerging Issues and Opportunities in Health Information Technology, a National Comprehensive Cancer Network Policy Summit, held June 27, 2016, in Washington, DC.

August 19th 2016

Health IT Essential for the Success of Cancer Moonshot

Surabhi Dangi-Garimella, PhD

Gregory C. Simon, executive director, White House Cancer Task Force, spoke at the National Comprehensive Cancer Network Policy Summit in Washington, DC. “Just like the original moonshot, the Cancer Moonshot is about using technology and the resulting information,” he said.

August 19th 2016

Dissolving Data Silos and Improving Access to Health IT Essential in Oncology Care

Surabhi Dangi-Garimella, PhD

At the Emerging Issues and Opportunities in Health Information Technology Policy Summit hosted by the National Comprehensive Cancer Network, on June 27, 2016, an afternoon panel discussed the role of technology and its importance in promoting dissemination of data.

August 19th 2016

Patients With Early Stage Lung Cancer More Susceptible to Dying Due to Air Pollution

Surabhi Dangi-Garimella, PhD

Survival in patients with early-stage lung cancer, particularly those with adenocarcinomas, may be shortened by air pollution, according to a study published in the journal Thorax.

August 18th 2016

Dr Michael Kolodziej on New Immuno-Oncology Agents And Payment Plans

The key in making coverage decisions about the integration of immuno-oncology agents into payment plans is being able to identify the patients who are most likely to benefit while also considering the long-term need for the acceptance of innovation in cancer care when faced with economic constraints, said Michael Kolodziej, MD, national medical director for oncology strategy at Aetna.

August 18th 2016

Shunning Unnecessary CA-125 and CT Testing in Ovarian Cancer Care Could Improve QOL and Lower Costs

Surabhi Dangi-Garimella, PhD

A new health services study in JAMA Oncology evaluated the impact of clinical evidence on routine surveillance in ovarian cancer, and found none.

August 17th 2016

Study Underscores Importance of Surveillance After Cancer

Jackie Syrop

One in 12 people who survive a common cancer will develop a second, unrelated malignancy, the most common of which was lung cancer.

August 17th 2016

USPSTF Reviews Skin Cancer Screening Recommendations

Cate Douglass

The USPSTF recently sought to update it's screening recommendations for skin cancer and evaluate the harms this type of test poses to the patient, and whether this tool leads to earlier detection of skin cancer than other care means.

August 16th 2016

Insurance Type, Race, and Distance to Clinic Primary Barriers for Breast Reconstruction Surgery

Surabhi Dangi-Garimella, PhD

Private insurance coverage and living closer to a plastic surgeon’s office encouraged women who had a mastectomy to undergo breast reconstruction, according to a recent study.

August 15th 2016

A Long Walk for Cigarettes Makes Smokers More Likely to Quit, Study Finds

Mary Caffrey

A commentary accompanying the study assets there's no question that targeted retail advertising makes it more likely that children will start smoking and less likely that adults will quit.

August 15th 2016

Cancer Patients View Their Prognosis Much Differently Than Physicians Without Ever Realizing It

Cate Douglass

New research published in JAMA discovered that patient-oncologist discordance was common among the cases studied, and patients were unaware that their opinions differed from their physician’s.

August 13th 2016

This Week in Managed Care: August 13, 2016

This week, the top stories in managed care include news on how Medicaid expansion improved health outcomes of low-income individuals, a report on how physical activity lowers risk of 5 common chronic conditions, and findings on how insurance type impacts health outcomes in cancer.

August 12th 2016

St. Jude's Research Discovers Links in Psychological Symptoms Among Adolescent Cancer Survivors

Cate Douglass

A recent study led by St. Jude Children’s Research Hospital discovered that cancer survivors who underwent the same or similar therapies displayed the same symptoms of mental health.

August 11th 2016

ASCO's Pain Management Guideline for Cancer Survivors Recommends a Comprehensive Approach

Surabhi Dangi-Garimella, PhD

An expert panel convened by the American Society of Clinical Oncology (ASCO) has issued a new clinical practice guideline on management of chronic pain in adult cancer survivors.

August 10th 2016

Study Finds Many Physicians Are Underestimating the Radiation Risk of CT Scans

Cate Douglass

Computed tomography (CT) scans, a common imaging modality, can increase a person's risk of developing cancer later in life.

August 10th 2016

Physical Activity Lowers Risk of 5 Common Chronic Diseases

Laura Joszt, MA

Higher levels of activity were associated with a significantly lowered risk for outcomes in 5 common chronic diseases; however, the largest gains were made at lower levels of activity with diminishing gains as activity levels increased.

...

89 90 91 92 93 94 95 96 97

...

181 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions